Copper toxicosis in a dairy goat herd.
METHODS
A closed herd of 400 mixed-breed dairy goats was examined because of a decrease in milk production and increase in mortality rate. Nine animals had died within a 1-month period.


RESULTS
Clinical signs were evident only in lactating goats and included anorexia and recumbency. In the most severely affected goats, signs progressed to neurologic abnormalities and death. Serum aspartate aminotransferase activity, gamma-glutamyltransferase activity, and total bilirubin concentration were high in clinically affected does, but no evidence of hemolysis was found. A diagnosis of copper toxicosis was made on the basis of high liver and kidney copper concentrations and histologic evidence of hepatic necrosis. Goats were found to have been fed a mineral mix containing 3,050 ppm copper for 9 months prior to the onset of copper toxicosis. Overall, there was no consistent relationship between serum hepatic enzyme activities, serum copper concentration, and liver copper concentration.


RESULTS
Clinically affected goats were treated with penicillamine, ammonium molybdate, sodium thiosulfate, and vitamin E. Penicillamine increased urine copper excretion in treated does versus untreated control animals. An increased incidence of infectious disease was identified in the herd 9 months later. Liver vitamin E concentration was low in 10 of the 12 goats that underwent necropsy.


CONCLUSIONS
Findings suggested that penicillamine may be an effective treatment for goats with copper toxicosis. Production losses months after the diagnosis was made suggested that the intoxication had a prolonged animal welfare and economic impacts.
Cornish
Jennifer
J
Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
Angelos
John
J
Puschner
Birgit
B
Miller
Grant
G
George
Lisle
L
D000821:Animal Feed / Q000009:adverse effects*; D000818:Animals; D000931:Antidotes / Q000627:therapeutic use*; D003300:Copper / Q000506:poisoning*; D005260:Female; D015511:Goat Diseases / Q000097:blood / Q000139:chemically induced* / Q000378:metabolism; D006041:Goats; D008099:Liver / Q000737:chemistry* / Q000201:enzymology; D008982:Molybdenum / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D011041:Poisoning / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary*; D013885:Thiosulfates / Q000627:therapeutic use; D014131:Trace Elements / Q000506:poisoning; D014810:Vitamin E / Q000627:therapeutic use
D000931:Antidotes; D013885:Thiosulfates; D014131:Trace Elements; D014810:Vitamin E; D003300:Copper; D008982:Molybdenum; D010396:Penicillamine; C017717:sodium thiosulfate; C022175:ammonium molybdate